This briefing is intended to provide an overview of AI incidents, in the context of the newly finished Code of Practice, a compliance tool under the AI Act for general purpose AI models. It covers a selection of past and ongoing incidents, the next frontier of incidents, and a list of possible actions for policymakers, divided into immediate, medium and long-term time horizons. Featured in Euractiv: https://www.euractiv.com/news/ai-rules-need-beefing-up-to-ensure-they-catch-c

Prominent voices, from Nobel Prize winning laureates, to MEPs, the independent expert drafters of the Code of Practice, and many others, have been calling for a bolstered AI Office to meet the demands of AI progress and risks. The following report explores this issue further, making international comparisons and policy recommendations. Nicolas Copernicus (Namesake of DG CNECT building housing the AI Office). Unsplash .  Key takeaways:  Enforcement capacity hinges on rapidly s

Over the past year, Pour Demain has worked closely with the AI Office, the independent expert Chairs and Vice Chairs, and other plenary...

A Joint Briefing by Pandemic Action Network, RAND Europe, IBBIS, Centre for Future Generations and Pour Demain The European Union (EU) is...

Illustration generated by Gamma The final draft of the EU’s Code of Practice  for general-purpose AI (GPAI) models is expected to be...

Pour Demain submitted a joint contribution with 14 co-signees to the European Commission’s Call for Evidence on the EU Biotech Act, alongside colleagues from academia, industry, and civil society. Our recommendations show how embedding biosecurity into EU biotech governance can strengthen innovation, bolster strategic autonomy, and build a high-trust bioeconomy.

The following is a fictional short-story about a remote third-party general purpose AI audit, occurring within the EU in the year 2028....

Pour Demain, en collaboration avec Blueprint Biosecurity et RAND Europe, a soumis des commentaires sur deux consultations de l'UE : la...

The following is an excerpt of an op-ed published by Pour Demain in Tech Policy Press . The article provides nuance to the innovation vs...

Current geopolitical tensions and rapid technological developments have necessitated an urgent reassessment of biological risks and their...